Book Value Per Share: The amount of equity available to shareholders expressed on a per common share basis. Calculated as: Total Shareholders Equity / Common Shares Outstanding
Vitro Diagnostics (VODG) had Book Value Per Share of $-2.71 for the most recently reported fiscal quarter, ending 2025-07-31.
| Income Statement Financials | |
$0.61M |
|
$-1.70M |
|
$0.07M |
|
$0.54M |
|
$1.50M |
|
$-0.89M |
|
$-0.81M |
|
$-1.70M |
|
$-1.70M |
|
$-1.70M |
|
$-1.70M |
|
$-1.70M |
|
$-1.70M |
|
$-0.89M |
|
$-0.03M |
|
4.46M |
|
4.46M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$0.65M |
|
$0.06M |
|
$3.98M |
|
$4.63M |
|
$14.93M |
|
$1.16M |
|
$1.78M |
|
$16.71M |
|
$-12.08M |
|
$-15.74M |
|
$-12.08M |
|
4.46M |
|
| Cash Flow Statement Financials | |
$-1.80M |
|
$-0.07M |
|
$1.47M |
|
$0.57M |
|
$0.18M |
|
$-0.40M |
|
$1.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.04 |
|
-- |
|
-- |
|
-0.11 |
|
-0.45 |
|
88.56% |
|
-146.25% |
|
-146.25% |
|
-- |
|
-279.07% |
|
-279.71% |
|
$-1.80M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.40 |
|
2.70 |
|
33.32 |
|
14.06% |
|
10.79% |
|
-36.70% |
|
15.56% |
|
|
Book Value Per Share |
$-2.71 |
$-0.40 |
|
$-0.40 |
|